UK markets close in 8 hours 23 minutes

Trellus Health plc (TRLS.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.9400+0.0400 (+2.11%)
As of 04:35PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 3.13M
Enterprise value -6.57M
Trailing P/E 5.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)206.80
Price/book (mrq)0.20
Enterprise value/revenue -345.71
Enterprise value/EBITDA 1.08

Trading information

Stock price history

Beta (5Y monthly) 0.10
52-week change 3-75.75%
S&P500 52-week change 324.49%
52-week high 39.6500
52-week low 30.0000
50-day moving average 32.4958
200-day moving average 34.4970

Share statistics

Avg vol (3-month) 3386.39k
Avg vol (10-day) 3723.48k
Shares outstanding 5161.51M
Implied shares outstanding 6161.51M
Float 891.92M
% held by insiders 146.39%
% held by institutions 127.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-61,080.00%

Management effectiveness

Return on assets (ttm)-18.41%
Return on equity (ttm)-28.43%

Income statement

Revenue (ttm)19k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-37.50%
Gross profit (ttm)N/A
EBITDA -6.74M
Net income avi to common (ttm)-6.34M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.17M
Total cash per share (mrq)0.08
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)15.69
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-5.27M
Levered free cash flow (ttm)-5.78M